Risk-adjusted outcomes for mental health trusts. by Paris Pariza (21237935)

Subjects:

Risk-adjusted outcomes for acute hospital trusts. by Paris Pariza (21237935)

Subjects:

Energy efficiency variation across cities in the Greater Bay Area. by YanFei Lei (19532983)

Subjects:

Drug company payments to NHS foundation trusts and non-foundation NHS trusts, 2015–2018. by Piotr Ozieranski (7640876)

Subjects:

Descriptive statistics for the trust in healthcare system scale. by Željko Pavić (12174363)

The percentage of studies that resulted in insect death increased over time. by Craig D. Perl (3326880)

Subjects:

The results of GO functional enrichment analysis (Annotation: The higher the value, the greater the importance). by Lin Zhou (141050)

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

Heterogenous treatment effect on vaccination intentions by trust in government institutions. by Ulrich T. Jensen (12359589)

Subjects:

Sobel test for the significance of the mediation effect. by Getachew Magnar Kitila (19935139)

Results of logistic regression for predictors of COVID-19 vaccine trust and hesitancy. by Hocheol Lee (3958376)

Subjects:

Posterior, mid-posterior, central, and mid-anterior corpus callosal volume significantly decreased with increasing risk of environmental lead exposure. by Andrew T. Marshall (10159199)

Results of the test of social trust influence mechanism. by Chuanyi Liu (18142450)

Subjects:

Significant VAR coefficients for the simple lag-1 model. by Ignacio Ojea Quintana (14058199)

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

Table_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_3_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”

Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Furthermore, a significant decrease in brain uptake of the TSPO PET tracer [¹⁸F]DPA-714 was observed with viniferin compared to resveratrol. …”